Lataa...
A phase III randomized controlled trial of radiation dose optimization in non‐Hodgkin lymphoma‐diffuse large B‐cell lymphoma (DOBL study): Study protocol and design
BACKGROUND: Radiation therapy for diffuse large B‐cell lymphoma (DLBCL) has shown improvement in progression free survival. There is uncertainty about the optimal radiation dose, with heterogeneous doses being used, ranging from 30 to 55 Gy. This trial tests the efficacy of using reduced radiation d...
Tallennettuna:
| Julkaisussa: | Cancer Rep (Hoboken) |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941552/ https://ncbi.nlm.nih.gov/pubmed/32935480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1161 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|